(4R)-8-(8-quinolin-4-ylsulfanyl-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl)-8-azaspiro[4.5]decan-4-amine
C23H25N7S — CID 139427829
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4R)-8-(8-quinolin-4-ylsulfanyl-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl)-8-azaspiro[4.5]decan-4-amine
(4R)-8-(8-quinolin-4-ylsulfanyl-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl)-8-azaspiro[4.5]decan-4-amine (PubChem CID 139427829) has the molecular formula C23H25N7S and a molecular weight of 431.57 g/mol. Its IUPAC name is (4R)-8-(8-quinolin-4-ylsulfanyl-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl)-8-azaspiro[4.5]decan-4-amine.
Molecular Properties
| Compound Name | (4R)-8-(8-quinolin-4-ylsulfanyl-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl)-8-azaspiro[4.5]decan-4-amine |
|---|---|
| PubChem CID | 139427829 |
| Molecular Formula | C23H25N7S |
| Molecular Weight | 431.57 g/mol |
| Exact Mass | 431.19 |
| IUPAC Name | (4R)-8-(8-quinolin-4-ylsulfanyl-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl)-8-azaspiro[4.5]decan-4-amine |
| SMILES | N[C@@H]1CCCC12CCN(c1ncc(Sc3ccnc4ccccc34)c3nncn13)CC2 |
| InChI | InChI=1S/C23H25N7S/c24-20-6-3-8-23(20)9-12-29(13-10-23)22-26-14-19(21-28-27-15-30(21)22)31-18-7-11-25-17-5-2-1-4-16(17)18/h1-2,4-5,7,11,14-15,20H,3,6,8-10,12-13,24H2/t20-/m1/s1 |
| InChIKey | IGPSYSVSSUJQNA-HXUWFJFHSA-N |
| XLogP | 3.92 |
| TPSA | 85.23 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 431.57 |
| LogP ≤ 5 | 3.92 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139427829 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.